IE911625A1 - New sulphonyl compounds - Google Patents

New sulphonyl compounds

Info

Publication number
IE911625A1
IE911625A1 IE162591A IE162591A IE911625A1 IE 911625 A1 IE911625 A1 IE 911625A1 IE 162591 A IE162591 A IE 162591A IE 162591 A IE162591 A IE 162591A IE 911625 A1 IE911625 A1 IE 911625A1
Authority
IE
Ireland
Prior art keywords
denotes
compounds
salts
alkyl
methyl
Prior art date
Application number
IE162591A
Other languages
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IE911625A1 publication Critical patent/IE911625A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat Treatment Of Steel (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE162591A 1990-05-16 1991-05-13 New sulphonyl compounds IE911625A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH165890 1990-05-16

Publications (1)

Publication Number Publication Date
IE911625A1 true IE911625A1 (en) 1991-11-20

Family

ID=4215610

Family Applications (1)

Application Number Title Priority Date Filing Date
IE162591A IE911625A1 (en) 1990-05-16 1991-05-13 New sulphonyl compounds

Country Status (23)

Country Link
US (1) US5346904A (https=)
EP (1) EP0528922B1 (https=)
JP (1) JP3238397B2 (https=)
CN (1) CN1027507C (https=)
AT (1) ATE181330T1 (https=)
AU (1) AU651592B2 (https=)
CA (1) CA2082923C (https=)
CS (1) CS144791A3 (https=)
DE (3) DE4191109D2 (https=)
DK (1) DK0528922T3 (https=)
ES (1) ES2134777T3 (https=)
FI (1) FI925005L (https=)
GR (1) GR3031098T3 (https=)
HU (2) HUT62895A (https=)
IE (1) IE911625A1 (https=)
IL (1) IL98133A (https=)
MY (1) MY105344A (https=)
NO (1) NO924414L (https=)
NZ (1) NZ238141A (https=)
PT (1) PT97680B (https=)
WO (1) WO1991017991A1 (https=)
YU (1) YU85691A (https=)
ZA (1) ZA913627B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612247A1 (de) * 1991-11-15 1994-08-31 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von sulfonylverbindungen
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
EE03829B1 (et) * 1996-11-11 2002-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
JP2001514640A (ja) * 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
CA2291153A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
DE69828284T2 (de) 1997-06-30 2005-12-08 Nippon Kayaku K.K. Naphthyridinderivate oder salze davon
EP1212089B1 (en) 1999-08-21 2006-03-22 ALTANA Pharma AG Synergistic combination of roflumilast and salmeterol
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8196556B2 (en) * 2009-09-17 2012-06-12 Delphi Technologies, Inc. Apparatus and method for setting mechanical lash in a valve-deactivating hydraulic lash adjuster
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
US4087530A (en) * 1974-02-05 1978-05-02 Sandoz Ltd. Substituted 6-phenyl-octahydrobenzo [c] [1,6] naphthyridines
DE2503156A1 (de) * 1974-02-05 1975-08-07 Sandoz Ag Verfahren zur herstellung neuer heterocyclischer verbindungen
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin

Also Published As

Publication number Publication date
AU7870191A (en) 1991-12-10
EP0528922A1 (de) 1993-03-03
MY105344A (en) 1994-09-30
HU9203557D0 (en) 1993-03-29
ZA913627B (en) 1992-01-29
DE4191109A1 (https=) 1993-04-01
CS144791A3 (en) 1992-03-18
NO924414D0 (no) 1992-11-16
DE59109135D1 (de) 1999-07-22
JPH05507081A (ja) 1993-10-14
CN1056691A (zh) 1991-12-04
DK0528922T3 (da) 1999-11-22
IL98133A (en) 1994-11-11
NZ238141A (en) 1993-07-27
PT97680A (pt) 1992-02-28
DE4191109D2 (en) 1993-04-01
CA2082923C (en) 2001-12-18
WO1991017991A1 (de) 1991-11-28
NO924414L (no) 1992-11-16
HUT62895A (en) 1993-06-28
YU85691A (sh) 1994-06-24
PT97680B (pt) 1998-09-30
ATE181330T1 (de) 1999-07-15
CA2082923A1 (en) 1991-11-17
GR3031098T3 (en) 1999-12-31
FI925005A7 (fi) 1992-11-05
FI925005A0 (fi) 1992-11-05
FI925005L (fi) 1992-11-05
EP0528922B1 (de) 1999-06-16
AU651592B2 (en) 1994-07-28
US5346904A (en) 1994-09-13
CN1027507C (zh) 1995-01-25
ES2134777T3 (es) 1999-10-16
JP3238397B2 (ja) 2001-12-10
IL98133A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
US5346904A (en) Sulphonyl compound
US6025367A (en) Sulfonamide derivatives as 5HT7 receptor antagonists
PL188908B1 (pl) Nowe pochodne benzimidazolu i ich zastosowanie dowytwarzania leków do leczenia stanów alergicznych
CA1168232A (en) Isoquinoline derivatives, a process for their preparation, pharmaceutical formulations containing them and their use
WO1996011930A1 (en) Cns-active pyridinylurea derivatives
JP2005525332A (ja) ５−ｈｔ６受容体アフィニティーを有するスルホニル化合物
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
PL160574B1 (pl) Sposób wytwarzania nowych pochodnych aminoalkoksyfenylu PL PL
EP0093521B1 (en) Quinoline derivatives
IE42978B1 (en) Triaryl alkyl azabicyclo compounds
US5635511A (en) Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds.
US4176184A (en) Imidazoisoquinoline-diones and salts thereof
JP2002501920A (ja) セロトニン−１ａ受容体作動薬としてのオキサゾール誘導体
JP2000512306A (ja) ５―ｈｔ―２ｃ受容体アンタゴニストとして有用なインドリン誘導体
US4607040A (en) Quinoline derivatives which are 5-hydroxytryptamine antagonists
KR850000126B1 (ko) 이미다졸 유도체의 제조방법
US5059607A (en) Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists
JPS61158980A (ja) ８α‐アシルアミノエルゴリン類、その製法および医薬組成物
EP0204003A1 (en) 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, process for their preparation, and medicinal composition containing same
US4410536A (en) 7,8,9,10-Tetrahydrothieno[3,2-e]pyrido[4,3-b]indole compounds and their anti-depressant use
US20030097000A1 (en) 2-Phenyl-quinoline derivatives, preparation method and therapeutic use thereof
US4681881A (en) 5-alkoxy-pyrido[4,3-d]pyrimidine derivatives
JPS5867673A (ja) イミドスルフアミド誘導体
JPS62108863A (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
US3903091A (en) 1,2,3,4-Tetrahydroisoquinoline derivatives